EG12969A - Process for preparing of novel 1-benzazolylalkyl-4-substituted piperadines - Google Patents

Process for preparing of novel 1-benzazolylalkyl-4-substituted piperadines

Info

Publication number
EG12969A
EG12969A EG605/76A EG60576A EG12969A EG 12969 A EG12969 A EG 12969A EG 605/76 A EG605/76 A EG 605/76A EG 60576 A EG60576 A EG 60576A EG 12969 A EG12969 A EG 12969A
Authority
EG
Egypt
Prior art keywords
benzazolylalkyl
preparing
novel
piperadines
substituted
Prior art date
Application number
EG605/76A
Other languages
English (en)
Inventor
J Vandenberk
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of EG12969A publication Critical patent/EG12969A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
EG605/76A 1975-10-08 1976-10-05 Process for preparing of novel 1-benzazolylalkyl-4-substituted piperadines EG12969A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62072775A 1975-10-08 1975-10-08
US05/713,309 US4035369A (en) 1975-10-08 1976-08-10 1-Benzazolylalkyl-4-substituted-piperidines

Publications (1)

Publication Number Publication Date
EG12969A true EG12969A (en) 1981-03-31

Family

ID=27088773

Family Applications (1)

Application Number Title Priority Date Filing Date
EG605/76A EG12969A (en) 1975-10-08 1976-10-05 Process for preparing of novel 1-benzazolylalkyl-4-substituted piperadines

Country Status (31)

Country Link
US (1) US4035369A (ja)
JP (1) JPS5246082A (ja)
AT (1) AT365185B (ja)
AU (1) AU511834B2 (ja)
BG (1) BG27542A3 (ja)
CA (1) CA1085853A (ja)
CH (1) CH630915A5 (ja)
CS (1) CS225101B2 (ja)
DE (1) DE2645125A1 (ja)
DK (1) DK151801C (ja)
EG (1) EG12969A (ja)
ES (1) ES452200A1 (ja)
FI (1) FI63228C (ja)
FR (1) FR2346009A1 (ja)
GB (1) GB1532546A (ja)
GR (1) GR61672B (ja)
HU (1) HU174927B (ja)
IE (1) IE43951B1 (ja)
IL (1) IL50631A (ja)
IT (1) IT1069293B (ja)
LU (1) LU75954A1 (ja)
NL (1) NL7611085A (ja)
NO (1) NO144926C (ja)
NZ (1) NZ182134A (ja)
PH (1) PH15417A (ja)
PL (1) PL106815B1 (ja)
PT (1) PT65688B (ja)
RO (1) RO69904A (ja)
SE (1) SE417610B (ja)
SU (1) SU663306A3 (ja)
YU (1) YU39976B (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
EP0034116A3 (en) * 1980-02-11 1981-09-02 Berlex Laboratories, Inc. N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
US4254127A (en) * 1980-04-03 1981-03-03 Janssen Pharmaceutica, N.V. 1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives
DE3442757A1 (de) * 1984-11-23 1986-05-28 Wella Ag, 6100 Darmstadt Verwendung von 2-nitroanilinderivaten in haarfaerbemitteln und neue 2-nitroanilinderivate
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
FR2702214B1 (fr) * 1993-03-05 1995-04-14 Adir Nouveaux composés (aryl(alkyl)carbonyl)-hétérocycliques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
GB9418326D0 (en) * 1994-09-12 1994-11-02 Lilly Industries Ltd Pharmaceutical compounds
ATE247114T1 (de) 1994-09-12 2003-08-15 Lilly Co Eli Serotonergische modulatoren
GB2308362A (en) * 1995-12-19 1997-06-25 Lilly Industries Ltd Pharmaceutical indole derivatives
GB9613423D0 (en) * 1996-06-26 1996-08-28 Lilly Industries Ltd Pharmaceutical compounds
EP2064227A2 (en) * 2006-09-19 2009-06-03 Cipla Ltd. Processes for the preparation of ciclesonide and its crystal form
CN101759693B (zh) * 2008-12-23 2011-09-14 江苏恩华药业股份有限公司 苯骈异恶唑哌啶衍生物及在制备镇痛、镇静药物中的应用
CA3211341A1 (en) * 2021-03-19 2022-09-22 Centre National De La Recherche Scientifique Applications of biased ligands of the serotonin 5-ht7 receptor for the treatment of pain, multiple sclerosis and the control of thermoregulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE633495A (ja) * 1962-06-13
US3225052A (en) * 1964-05-06 1965-12-21 Janssen Pharmaceutica Nv Benzimidazolinyl piperidine derivatives
FR1573739A (ja) 1968-07-26 1969-07-04
US3635982A (en) * 1969-04-08 1972-01-18 American Home Prod Amino-substituted-quinoxalinyloxazolidines and -oxazines

Also Published As

Publication number Publication date
FR2346009B1 (ja) 1978-12-22
CA1085853A (en) 1980-09-16
AT365185B (de) 1981-12-28
IL50631A (en) 1980-02-29
IL50631A0 (en) 1976-12-31
DE2645125C2 (ja) 1988-11-24
JPS5246082A (en) 1977-04-12
HU174927B (hu) 1980-04-28
FR2346009A1 (fr) 1977-10-28
SE7611137L (sv) 1977-04-09
FI63228B (fi) 1983-01-31
US4035369A (en) 1977-07-12
FI762865A (ja) 1977-04-09
CS225101B2 (en) 1984-02-13
DE2645125A1 (de) 1977-04-21
NO144926C (no) 1981-12-09
PH15417A (en) 1983-01-07
DK452076A (da) 1977-04-09
SU663306A3 (ru) 1979-05-15
BG27542A3 (bg) 1979-11-12
ES452200A1 (es) 1978-01-16
YU248076A (en) 1983-01-21
IT1069293B (it) 1985-03-25
PL106815B1 (pl) 1980-01-31
AU1807876A (en) 1978-04-06
LU75954A1 (ja) 1977-05-09
PT65688B (en) 1978-04-02
GB1532546A (en) 1978-11-15
YU39976B (en) 1985-06-30
JPS6215553B2 (ja) 1987-04-08
GR61672B (en) 1978-12-05
DK151801C (da) 1988-06-06
NO763424L (ja) 1977-04-13
PT65688A (en) 1976-11-01
SE417610B (sv) 1981-03-30
ATA745276A (de) 1981-05-15
DK151801B (da) 1988-01-04
PL192890A1 (pl) 1978-03-28
RO69904A (fr) 1980-08-15
NL7611085A (nl) 1977-04-13
AU511834B2 (en) 1980-09-11
CH630915A5 (de) 1982-07-15
FI63228C (fi) 1983-05-10
IE43951B1 (en) 1981-07-01
NZ182134A (en) 1979-01-11
IE43951L (en) 1977-04-08
NO144926B (no) 1981-08-31

Similar Documents

Publication Publication Date Title
GB1547802A (en) Process for the preparation of poly-phenyleneterephthalamide
YU39479B (en) Process for the manufacture of thieno-pyridine derivatives
HU171396B (hu) Sposob poluchenija proizvodnykh rifamicina
GB1517423A (en) Process for the preparation of diaryl-carbonates
EG12969A (en) Process for preparing of novel 1-benzazolylalkyl-4-substituted piperadines
YU39081B (en) Process for preparing new derivatives of oxadiazolinones
EG12413A (en) Process for preparing of 11-desoxy-16-aryloxy-pentanorprostaglandins
PT64878B (en) Process for the preparation of new indolylalkylpiperidines
HU171395B (hu) Sposob poluchenija proizvodnykh rifamicina
EG12255A (en) Process for preparing of benzophenones derivatives
CH608786A5 (en) Process for the preparation of acetoacetylarylamides
GB1534077A (en) Process for the preparation of 5-acetoacetylamino-benzimidazolone
EG12383A (en) Process for preparing of depot-steroidester
CS189782B2 (en) Process for preparing derivatives of diaminoandrostane
YU50576A (en) Process for obtaining derivatives of 4-oxohexahydro-piperazinoisoquinoline
EG12328A (en) Process for preparing of substituted 2-phenylimino-1,3-dithiolanes
CS186234B2 (en) Process for preparing new derivatives of ferocene
CS191319B2 (en) Process for preparing derivatives of 2-nitro-3-phenylbenzofurane
CS191308B2 (en) Process for preparing derivatives of diarylhydroxybutylamines
CS191981B2 (en) Process for preparing derivatives of 5-androsten-17-one
YU187676A (en) Process for preparing new derivatives of triaminoandrostane
JPS5233653A (en) Process for manufacture of nnalicyclic crbamate
CS191322B2 (en) Process for preparing new disubstituted phenolethers of 3-amino-2-hydroxypropane
PT65754A (en) Process for preparing novel derivatives of aroyl-phenylindenes and aroyl-phenylnaphthalenes
CS189751B2 (en) Process for preparing derivatives of diphenyletheres